Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
7th grade Avg
|
New words:
ability, abroad, achieve, adapt, additionalZOTON, administered, advantage, affiliated, aggressive, allocated, andALESSE, andCALTRATE, andDIMETAPP, andEFFEXOR, andENBREL, andINDERAL, ANDMANAGEMENT, Andover, andPONDIMIN, andPREMARIN, andPREMPHASE, andREDUX, andREFACTO, andTYGACIL, antibiotic, antidepressant, array, articulated, asLOETTEinternationally, asPREMARIN, asTAZOCIN, attendant, attention, attractive, Australia, beneficial, BENEFIXCoagulation, bioequivalence, biopharmaceutical, bowel, broad, BTPC, building, calculate, candidate, caution, cautionary, certainty, Chain, Chairman, characterized, circumvented, clean, clinical, coat, combat, compete, competing, complex, component, comprehensive, conflicting, constipation, context, contractual, contrary, contrast, convenient, Corrupt, costly, counterfeit, counterpart, coverage, Criteria, critical, CSM, currency, daily, dedicate, degree, depleted, depressive, desvenlafaxine, detail, devote, difficult, Difficulty, diminish, diminished, disadvantage, discount, discounted, disorder, disrupted, distinct, distributor, Diversion, divert, DNA, dollar, dose, dosing, drugsPONDIMIN, dysfunction, EFEXORinternationally, emerging, encourage, enrolling, ensure, environment, estimate, estimated, eventual, Excellence, expansion, Expenditure, experienced, export, expressly, face, fail, false, Fee, FINANCIALCONDITION, firm, flow, fluctuation, force, forecast, forLYBREL, formulary, forPREMARIN, ForRAPAMUNE, forZOTON, franchise, frequently, fromZOTON, furnished, Ganzi, Graph, grown, Guaranty, hand, hedge, hereof, highlight, historical, Hofstaetter, identified, illustrative, immaterial, immunopharmaceutical, impede, implied, imposition, improperly, inability, inaccurate, includingADVIL, includingALTACE, includingCHAPSTICK, includingCYDECTIN, includingEFFEXOR, includingPREVNAR, includingRAPAMUNE, includingWEST, includingZOSYN, inclusion, increasingly, inflammatory, inPREVNAR, inRAPAMUNE, inside, instability, interrupt, interval, issuer, itsEFFEXOR, Johnson, JPMorgan, launch, launchedTYGACIL, lead, lengthy, licensor, Likewise, local, lot, lowest, maintenance, manner, meet, menstrual, methamphetamine, methylnaltrexone, milestone, mix, model, Modernization, modular, molecular, molecule, monophasic, month, multiple, narrow, NILE, Nominating, obligation, ofDIMETAPP, ofEFFEXOR, ofENBREL, offset, ofPROTONIX, ofREFACTO, onALTACE, onEFFEXOR, onENBREL, onPROTONIX, opposite, ourEFFEXOR, package, packaging, partially, pathway, patient, pension, percentage, pertaining, political, population, portfolio, Portwood, position, preclinical, preclude, PREMARINfamily, prevail, PREVENARinternationally, Priority, professional, profitability, prominently, promptly, proprietary, PROTONIXandALTACE, prove, pseudoephedrine, punishable, qualified, quantity, readily, real, recoup, reduction, referenced, regimen, reliance, rely, remediation, Ren, rental, reproduced, reputation, Restoration, reuptake, safer, sample, Sanford, satisfy, scope, scrutiny, seasonal, seasoned, secret, sector, seizure, Selected, Selection, selective, serotonin, service, shell, shift, shown, side, size, slowdown, small, SMIP, SNRI, Solvay, specialty, spend, spending, spent, SSRI, staffing, standard, statistical, STOCKHOLDER, strategic, Strategy, stringent, subsidized, substitute, succeed, succinate, Sufficiency, sufficient, sufficiently, supervision, SUPPLEMENTARY, suspended, synthetic, Table, targeted, Technical, terrorist, theCYPHER, theEFFEXOR, thePREMARIN, theREDUX, thereof, theROBITUSSIN, toEFFEXOR, toENBREL, toPROTONIX, treasury, Trubion, Trustee, unable, unacceptable, Unaffiliated, unanticipated, Unaudited, uncertainty, undesirable, unfavorable, unnumbered, unresolved, unsuccessful, upward, variety, Victor, view, viewed, volatility, voluntary, welfare, written
Removed:
Abbott, acetate, added, ADVIL, affirmed, Agricultural, Aktiengesellschaft, al, Alabama, ALAVERT, Albertson, Alexander, allege, allegedly, ALTACE, announced, approving, area, Ariz, arm, Ashton, asserted, assignee, attorney, audited, autism, AWP, Barr, BASF, bench, BENEFIX, billion, book, Brasil, Brazil, Brazilian, breast, bring, ca, Cal, California, Carrion, Castaldi, causation, CDC, certiorari, child, childhood, Chimento, chloride, Cir, Circ, Circuit, Civ, Clifford, Cobalt, Comm, competitor, complaint, consortium, contaminated, Cook, Coordination, County, covered, Ct, Cty, CV, CYDECTIN, Cyr, Dade, Daigle, decision, denied, determined, DIMETAPP, discontinued, disgorgement, dismissed, Dist, Docket, DURACT, Duramed, enrichment, exceed, exposed, factual, favor, feed, FL, Francisco, fund, funded, Gallo, Garcia, Genentech, HCl, heart, hemorrhagic, Hillsborough, Home, IBEP, Ill, implantable, INDERAL, indirect, infringement, inherently, injunctive, injured, inquiry, intermediate, Jud, judge, jurisdiction, jury, KSH, la, lawsuit, learned, levonorgestrel, livestock, Los, Ltda, LWWL, MA, matrix, MDL, Mead, merger, mg, miscarriage, MPA, NH, NJ, norplant, Ontario, opt, originally, pa, panel, Parish, participating, Pasteur, payer, people, personnel, Phil, Philadelphia, plaintiff, police, PONDIMIN, postmenopausal, PPA, PPH, prejudice, preliminary, PREMARIN, PREMPRO, PREVENAR, proceed, proceeding, punitive, purported, pursue, putative, ramipril, RAPAMUNE, recorded, recovery, REDUX, refining, regurgitation, released, relief, remand, Rene, replace, residing, resolved, resolving, Richland, ROBITUSSIN, ruling, San, scheduled, Schering, screening, SDE, seek, Shadie, solgar, ss, stage, statewide, statute, step, stroke, study, Suffolk, Super, Supreme, SvG, Swanston, taxable, thimerosal, Turner, unlawfully, unpredictable, valve, venlafaxine, verdict, violate, Wax, Wilson, WMI, work, writ, WV, ZOSYN
Filing tables
Filing exhibits
- 10-K Annual report
- 10.9 License Agreement, Dated As of December 13, 2005
- 12 Computation of Ratio of Earnings to Fixed Charges
- 13 2005 Financial Report to Stockholders
- 21 Subsidiaries of the Company
- 23 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of the CEO Pursuant to Section 302
- 31.2 Certification of the CFO Pursuant to Section 302
- 32.1 Certification of the CEO Pursuant to Section 906
- 32.2 Certification of the CFO Pursuant to Section 906
Related press release
WYE similar filings
Filing view
External links